Environmental, Social And Governance Report

Overview

The report describes Hua Medicine's 2020 clinical progress, including completion of Phase III registration trials and 52-week DAWN results. It also highlights the strategic diabetes collaboration with Bayer and the Drug Manufacturing Permit for dorzagliatin. On sustainability, the Group reports resource consumption, indirect greenhouse gas emissions and initiatives for greener operations. Employee initiatives included 26 training sessions, 61 trained employees and 2,454 training hours.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services